Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare (SRTS)
NASDAQ:SRTS
Holding SRTS?
Track your performance easily
Earnings Data
Report Date
Feb 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.12Last Year’s EPS
0.26Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: 13.03%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter for Sensus Healthcare with significant revenue growth and strategic partnerships, particularly the large agreement with Platinum Dermatology Partners. However, there is some concern over seasonality effects and reliance on a key customer. Overall, the outlook remains positive with solid international expansion and improved profitability.Company Guidance
During the Q3 2024 earnings call for Sensus Healthcare, the executives provided guidance on various metrics that highlighted their growth trajectory. Revenues for the quarter more than doubled year-over-year, reaching $8.8 million, driven by the shipment of 27 SRT systems, compared to 11 in the same period last year. The company signed seven new Fair Deal Agreement (FDA) contracts in Q3, bringing the total to 22 agreements. A significant milestone was the exclusive agreement with Platinum Dermatology Partners, which covers all 130 clinical sites in the U.S., marking the largest sale under FDA to date. The gross profit margin improved to 59.3% from 51% in the previous year, and the net income was reported at $1.2 million, or $0.07 per diluted share, compared to a net loss of $1.5 million, or a loss of $0.09 per share, in Q3 2023. Adjusted EBITDA for the quarter was $1.6 million, reflecting a year-over-year improvement of more than $3.3 million. The company's cash and cash equivalents stood at $22.6 million as of September 30, 2024, with no outstanding borrowings, indicating a strong balance sheet prepared for future growth opportunities.Significant Revenue Growth
Revenues for Q3 2024 more than doubled to $8.8 million, up 127% from $3.9 million in Q3 2023.
Record SRT System Shipments
Shipped 27 SRT systems in Q3 2024 compared to 11 in the same quarter last year.
Strategic Partnership with Platinum Dermatology
Entered an exclusive agreement with Platinum Dermatology Partners covering all 130 clinical sites.
International Expansion
Shipped SRT systems to Israel and Swedish Hospital in Seattle, indicating global growth.
Improved Profitability
Net income for Q3 2024 was $1.2 million compared to a net loss of $1.5 million in Q3 2023.
Strong Adjusted EBITDA Growth
Adjusted EBITDA for Q3 2024 was $1.6 million compared to negative $1.7 million in Q3 2023.
---
SRTS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SRTS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $7.29 | $7.64 | +4.80% |
| Aug 08, 2024 | $6.30 | $6.39 | +1.43% |
| May 09, 2024 | $3.81 | $5.29 | +38.85% |
| Feb 08, 2024 | $3.65 | $3.88 | +6.30% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sensus Healthcare (SRTS) report earnings?
Sensus Healthcare (SRTS) is schdueled to report earning on Feb 06, 2025, TBA Not Confirmed.
What is Sensus Healthcare (SRTS) earnings time?
Sensus Healthcare (SRTS) earnings time is at Feb 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SRTS EPS forecast?
SRTS EPS forecast for the fiscal quarter 2024 (Q4) is 0.12.
---